alive and kicking
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dew,
I am not that well versed in word origins. Doofi sounded more sophisticated than doofuses.
doofus_king,
Thanks for living up to your name. You really are the king of the doofi!
So you think that is what is happening now with the emergence of the sky is falling gloom and doom crowd?
Dew,
It may be BS, but it is our BS.
Vinny
P.S. Any news about Flo?
<.... but I will take 95 cents anytime.>
Didn't you post this a few days ago? Are you going to keep repeating it every few days? I still spit on $0.95.
<1 month later, you may bet for it.>
I have already bet on it by investing in GTCB. You have made the same bet. What are you talking about?
I spit on $0.95!
Poor baby. Yes, by all means sell all your GTCB.
Did you invest in any other companes?
Flo,
I had been thinking of you and am glad your wife came through surgery well. I know how through it is to have a loved one with cancer.
It is critical that you go to a highly regarded cancer center, preferably one with a medical school. It would be worth it to try and go to Dana Farber Cancer Center directly for an appointment, assuming your wife is well enough to travel. It is far better to get direct involvement at Dana Farber for the initial assessment of the tumor biopsies, as well as to chart a course of than to go someplace affiliated with it, because such affiliations can be quite tenuous.
I would also point out that all cancer centers are not equal, so it is best to find out which centers have the most expertise in the type of cancer your wife has. It may well be Dana Farber is the place to go. Once the treatment and follow-up proceedures are in place, your more local cancer Center may be suitable to administer and monitor. However, you should still make sure to keep close tabs on how well they are keeping in contact with Dana Farber, or do so directly by an occasional email to the oncologist.
If you wish to contact me privately, use my email vinmantoo@yahoo.com
Vinny
P.S. Keep in mind that there is now a drug (Nexavar) that is proven effective in liver cancer, if it comes to chemotherapy. There are also very low invasive treatments (ablations) that can be used for localized liver tumors, and the person goes home that same day, as I know very well from my dad's liver cancer treatments.
crou,
Almost nobody pays attention to the platforms of either party. This is especially true of the nominees on the ticket. The platforms are for the delegates to act as if they have some control over the candidates, which of course they don't. It is pure theater, or if you prefer, smoke and mirrors.
<More important for GTC, both candidates are likely to sign FoB legislation—assuming that Congress ever gets around to passing it.>
Dew,
As usual you are on the money.
Both McCain and Obamam favor federal funding of stem cell research.
Flo,
Hope your are okay and that you will come through these health issues better than ever.
Crou,
Nothing about the current stock market conditions would surprise me. I wouldn't be surprised if GTCB dropped back under $0.40 or went back up to $0.70. Obviously I would enjoy the latter far more.
Dew, I think I would time my buys better if I were drinking during trading hours.
<Bullish Cup and Handle forming since May 2008?>
Yes. Fill the cup with beer and then drink deeply. Repeat when necessary.
I did not participate in the survey, but if I did I would have voted not to sell unless the price was over $10..
The HIV part was when GTCB made goats to supply PRO542, an anti-HIV protein, to PGNX. Since then PGNX has shelved, but not killed PRO542. They are moving forward with PRO140, a monoclonal anti-body that shows significianclty better efficacy. The phase II data for PRO140 should by the end of 2008.
Dew,
I asuemd that any resurrection of previous goat lines would be those making Remcade not Tysabri.
Dew,
I agree. Thanks so much for all your efforts.
Dew,
I am a bit surprised you would settle for $1.50 a share. I guess it would depend on how big the company is and if the offer was for shares of the purchasing company or cash outright. Personally, I would be quite disappointed if GTCB was bought out at $1.50 a share. I appreciate that would be a nice premium and end up giving me a small profit, but I didn't invest in GTCB to get a small profit.
<The Ovation deal and the submission will play 2nd fiddle to the cash flow headline IMO. People will begin to recognize a lowered annual cash burn going forward and real revenue possibilities within a few short years.>
That could be the biggest piece of news form this earnings report. We need to see Cox unequivocally state that the burn rate has been significantly cut by the Ovation deal. It seems to me the low trading volume is because everyone is waiting upon these key events, 1) finalization of the Ovation deal, 2) FDA submission, 3) cash burn reduction announcement, 4) the possibility of new cash being raised. The latter would hopefully come from an announcement of another deal with bigger up front money or an announcement of a loan from one of GTCB's partners would be far more welcome than another big dilution at these low prices.
GTCB has earnings???
Jesse,
I understand what you are saying and you make some valid points. However, while GTCB may have a plan, what is lacking is Cox publically acknowledging that they have a plan or plans to address the cash shortage. This should be pretty obvious to a CEO on the ball. An investor shouldn't have to dig into past agreements to deduce what they might do.
In the last conference call, Cox should have announced they he recognizes the need to raise more cash or reduce cash burn. He should state they are actively seeking multiple avenues to do so, including other partnerships, reducing cash burn (by suspending one or more projects, executive paycuts, work force reductions etc), alterations of future payments from partners to lower cash burn or acquire loans, and as a last resort, issuing more shares. When Cox doesn't mention these it comes off as he doesn't appreciate, care or even recognize that there is a serious cash crunch looming in a market where cash is hard to raise. Simply whining that the stock price is too low and he wants to get it higher isn't enough.
OT: emails.
Lew, Flo, Dew, Jesse
Thanks for your emails on Ihub. I don't check them very often and I am not a premium member there so I can't return emails. If you want to contact me, send emails to vinmantoo@yahoo.com
Thanks
Vinny
JohnBits,
You are pretty tiresome as well and your analogy is quite poor. Since you wish to engage in trivial and inaccurate analogies, I will indulge you. On the yahoo baord you compared GTCB to an experimental plane on fire. You chose to jump out and then pose the absurd choice of whether or not to use the parachute or not. Of course you would use the parachute. I will present a more accurate analogy and my subsequent course of actions. Yes I see the plane is on fire, but I don't immediately panic like you and abandon the ship by jumping out. You see the plane has some real value and can greatly impact future aviation. I first assess where the fire is, how fast is it spreading, what means I have to slow the fire or extinguish it. I also assess where the plane is currently located so if I decide that the best course of action is to jump, I can if necessary, fly the plane as far as possible to an area where my jump would give me the best chance to survive. Your immediate decision to abandon the plane could have left you landing on a glacier when you might have kept the plane flying long enough to jump into an open field near civilization. So you see, you study the options and make the best decision with the idea of delaying abandonment as long as possible.
Now back to reality and relevance. The move to the Nasdaq capital markets was just one of many possible actions that GTCB could have taken and the delaying of delisting was a consequence of that action. Both events are materially important to GTCB and its shareholders, regardless of what probability you attributed to them in the past, or do so now. In my view, it might have been the best option GTCB has right now, and gave us several more months of breathing room.
Your berating others for thinking that the shift to the Nasdaq capital markets isn't newsworthy just illustrates your dismissive view of all things GTCB. It also illustrates you aren't willing to engage in an honest discussion despite your repeated claims that you do. As I stated on ihub, we all expect that GTCB will submit rATIII to the FDA for approval in the next few weeks. When it does and is announced by GTCB, will you also dismiss this and the shareholders who post about it as posting old news or unimportant news because it is what we all expected?
Vinny
John,
Once again you look at news in a way to portray GTCB in the worst light. Moving to the NASDAQ Capital market and being granted an extension to avoid delisting is news and is something of a positive. Yes it was talked about but lots of things get talked about without coming to pass. We are awaiting GTCB filing for FDA approval and talked about that. I will be happy when that happens. We have also talked about getting other partners. I will be happy if that happens, especially if we can get a few milion more in up front cash. We have also talked about getting the phase II data for DIC. If it is positive, I will be very happy about that.
Dew,
Don't destroy my delusional state. It enabled me to retain some semblance of my sanity as GTCB price cratered. Just think of the joy each new day will now bring with a rise of a few mere pennies. Yeehaaa, I am having a ball again today...... so far.
Oldberkeley does it again!! Thanks. I am obviously the guy on the left holding a gun but mugging for the camera blissfully unaware of the danger around us, while just about everyone else is fixated on the danger to the right.
Vinny
P.S. Is Lew the guy laying down in the middle front and looking back at me in disbelief, as if I am some kind of a nut?
Flo,
There must be some mistake, GTCB is up today. I think you heard the rumor wrong. It wasn't oil wells but that GTCB is going to make oil out of goat sh*t. The next rumor will be that GTCB shares will soon be worth more than a dollar. The way things had been going, I would have been more likely to believe the former. However, today's rise makes me think both can come true!! Drinking tequila in the afternoon does open one's mind to all sorts of possibilities!!
As far as the ovation deal, here is the transcript from Dew's read me first.
<The milestone payments include a total of $9 million through approval of ATryn® for HD in the U.S., including $3 million paid upon closing and an additional $2 million expected to be received in 2008.>
There will be $5 million this year ($3 million up front and $2 million later this year)and an additional $4 million upon FDA approval. Future projects such as CABG/HR will be fully funded by Ovation.
I agree that we need a higher level of up front payments but please don't spin the Ovation deal as some kind of negative.
<The market is rallying. >
Right. So you are saying if GTCB goes up for one or two days, we can cry out that GTCB is rallying too.
<Not only is the technology fast, cheap and safe, but Levy said there's reason to expect that the plant-grown antibodies will generate a stronger immune response than those made in animal cells. Both plant and animal cells attach sugars to antibodies and other proteins during biochemical processing, but the plant and animal sugars are different. The difference might prompt a more robust immune response to plant-grown antibodies, Levy said.>
There is a balance. If the antibodies become too imunogenic, they could be cleared prior to binding the desired targets.
Where is #5?
That is the one where we crack open some champagne after #4 comes to pass.
Flo,
Is the DARK KNIGHT a pseudonym for investor8888 on the yahoo board?
Vinny
Flo,
<Any-who - regarding letters from Goat PEONS to the FDA -
the F.D.A sanitary engineers would FLUSH them down the Latrine ---->
That might clog the toilets. I say feed the letters to the goats. Not our prized GTCB goats, but some of the everyday common farm goats.
Vinny
polly,
I just assumed many of these hypocrites were meat eaters, but I love your veal and fois gras comment as well since it just emphasizes their hypocrcay. How many of thes morons do you think are diabetics? Do you think they will stop using insulin because of how much that medical treatment relied on animal research? Will they stop using monoclonal antibodies or any other protein produced in mammalian cell culture since mice had to die to make the monoclonals, a hampster had to die to make the CHO cells, and unborn calves as well as cows had to die to collect the fetal calf serum and bovine calf serum used to make the media needed to grow the CHO cells.
I will bet they don't care that so many people were infected with HIV and Hepatitis because of using blood and blood derived products, or that such problems and risks will be a thing of the past using GTCB's transgenic approach.
Vinny
I fully expected these lunatics to come forward with their lies, distortions and scaremongering. The birth defects they speak of are common for cloning not for transgenics. Second, once the transgenic lines are established, even the minor frequency of birth defects won't occur.
The funny thing is that if those hypocritical idiots really cared about animals, they would go after pet stores, farms, cattle ranchers, chicken farmers, pig farmers, fish farmers, commercial fishermen, dairy farmers, fur farmers and slaughterhouses. Those enterprises affect millions of animals and they many such animls live poor lives. In contrast, GTCB will only be dealing with a few hundred animals at most and these will live pampered lives far better than many or even most human beings .
crou,
I don't think one can assume Teva has sated its appetite for deals or partnerhips with the Barr Labs buyout.
gym gravity,
Thanks. I tired to works in a few more different difference but I think it would have obscured the hypocracy of big pharma. I used to work as a bench chemist in a major pharmaceutical company before going to graduate school to get my Ph.D. Once the management of big pharma senses a change in the environment by virtue of FDA approval of rATIII, the low cost production of valuable MAbs becomes viable. Then we will see the BP management lemmings shift and rush to get in the action. I was orginally hoping FDA approval of rATIII in the HD indication would do the trick, but am now think it will only begin to open the door. Positive phase II DIC data for rATIII would the trick for the stock price, but it may actually take postive results from Ovation in their phase III for CABG/HR to really shift BP sentiment.
Vinny